Takeda Pharmaceutical Co. (TAK) vs Viatris Inc. (VTRS)
- Takeda Pharmaceutical Co. TAK 19.67 +1.13%
- Viatris Inc. VTRS 18.66 +2.41%
Takeda Pharmaceutical Co. and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $61.9B against $20.9B — 3.0× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Takeda Pharmaceutical Co. trades at 29.6×. Viatris Inc. grew revenue faster over the last twelve months: 4.40% against 0.66%. Takeda Pharmaceutical Co. has the higher net margin (7.12% vs −2.79%) and the higher return on invested capital (2.88% vs −0.20%). Both pay a dividend; Viatris Inc. yields more (2.57% vs 1.57%). Across the 21 metrics below, Takeda Pharmaceutical Co. leads on 14 and Viatris Inc. on 7.
Valuation
Profitability
| Metric | TAK | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 34.83% | 53.94% |
| Operating margin | 11.61% | (0.59%) | 0.00% |
| Net margin | 7.12% | (2.79%) | 0.00% |
| Free cash flow margin | 24.74% | 12.83% | 0.00% |
| Return on equity | 4.42% | (2.75%) | (0.40%) |
| Return on assets | 2.15% | (1.12%) | (3.32%) |
| Return on invested capital | 2.88% | (0.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack